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86 The Journal of Thoracic and Cardiobjective: We previously applied non–risk-adjusted cumulative sum methods to
nalyze coronary bypass outcomes. The objective of this study was to assess the
ncremental advantage of risk-adjusted cumulative sum methods in this setting.
ethods: Prospective data were collected in 793 consecutive patients who under-
ent coronary bypass grafting performed by a single surgeon during a period of 5
ears. The composite occurrence of an “adverse outcome” included mortality or any
f 10 major complications. An institutional logistic regression model for adverse
utcome was developed by using 2608 contemporaneous patients undergoing cor-
nary bypass. The predicted risk of adverse outcome in each of the surgeon’s 793
atients was then calculated. A risk-adjusted cumulative sum curve was then
enerated after specifying control limits and odds ratio. This risk-adjusted curve was
ompared with the non–risk-adjusted cumulative sum curve, and the clinical sig-
ificance of this difference was assessed.
esults: The surgeon’s adverse outcome rate was 96 of 793 (12.1%) versus 270 of
815 (14.9%) for all the other institution’s surgeons combined (P  .06). The
on–risk-adjusted curve reached below the lower control limit, signifying excellent
utcomes between cases 164 and 313, 323 and 407, and 667 and 793, but trans-
ressed the upper limit between cases 461 and 478. The risk-adjusted cumulative
um curve never transgressed the upper control limit, signifying that cases preceding
nd including 461 to 478 were at an increased predicted risk. Furthermore, if the
isk-adjusted cumulative sum curve was reset to zero whenever a control limit was
eached, it still signaled a decrease in adverse outcome at 166, 653, and 782 cases.
onclusions: Risk-adjusted cumulative sum techniques provide incremental advan-
ages over non–risk-adjusted methods by not signaling a decrement in performance
hen preoperative patient risk is high.
oronary artery bypass grafting (CABG) is one of the most intensely scru-
tinized procedures in medicine, and its outcomes are often publicly dissem-
inated. Therefore, it is important that highly sensitive statistical methods be
sed to assess CABG outcomes. We previously used cumulative sum (CUSUM)
ailure techniques to analyze the transition from on-pump to off-pump CABG1 and
he learning curve in robotic-assisted cardiac procedures,2 and found that CUSUM
ethods were more sensitive than standard statistical techniques such as chi-square
esting in detecting an improvement or decrement in performance. Increasing
nterest has been paid recently to the role of CUSUM and other sequential proba-
ility ratio tests in the analysis of the outcomes of cardiac surgery procedures,3-6 and
he limitations of our previously described method of CUSUM analysis have been
ighlighted.4 In addition, it has been suggested that CUSUM and other sequential
robability ratio methods should be risk-adjusted to “level the playing field” with
vascular Surgery ● August 2006
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CDespect to the analysis of surgical outcomes. Nonetheless,
lthough the theoretic advantages of a risk-adjusted, as
pposed to a non–risk-adjusted CUSUM analysis, are pre-
umed, no direct comparison between the 2 techniques in a
ohort of patients undergoing CABG has, to our knowledge,
een published in the cardiac surgical literature. Further-
ore, the clinical significance of differences between the 2
echniques has not been demonstrated in patients undergo-
ng CABG.
During the past year we formed a multidisciplinary, multi-
nstitutional research group that presented risk-adjusted
USUM analyses after different types of surgical proce-
ures.7-9 We used a risk-adjusted CUSUM technique that
as developed by Steiner and associates10,11 and that was
sed to assess risk-adjusted mortality in a busy tertiary
eferral intensive care unit.12 In this study, we used this risk-
djusted CUSUM method to analyze a surgeon’s CABG
utcomes over a 5-year interval. We hypothesized that the
isk-adjusted CUSUM technique would prove superior to
on–risk-adjusted CUSUM methods in a direct “head-to-
ead” comparison and that this difference in outcomes
ould be clinically significant. Furthermore, we also ex-
lored the use of variable life-adjusted display (VLAD)
ethods4,13 as a complementary technique to assess CABG
utcomes.
atients and Methods
he subjects of this study included all patients undergoing elective
nd urgent CABG by a single surgeon and a group of 6 colleagues
t the London Health Sciences Centre, University Hospital, be-
ween July 1999 and December 2004. Detailed preoperative, op-
rative, and postoperative data were entered prospectively into a
ardiac surgery database that tracked postoperative outcomes. Al-
hough the date of onset of the study preceded a legislative re-
uirement that individual patient consent be routinely obtained, the
ead author asked the Research Ethics Board of the University of
estern Ontario to review and determine individual patient con-
ent requirements for this study. The Research Ethics Board issued
n exemption from this requirement on May 27, 1999. Moreover,
n a further review requested by the author the Research Ethics
oard of the University of Western Ontario approved the study on
une 20, 2005 (Review 11527E).
In this study, we used the composite occurrence of an “adverse
utcome” as our primary outcome variable, which included mor-
ality or any of 10 predefined major complications (stroke, reop-
ration for bleeding, mediastinitis, sepsis, sternal dehiscence, new
Abbreviations and Acronyms
ARL  average run length
CABG  coronary artery bypass grafting
CUSUM cumulative sum
VLAD  variable life-adjusted displayntra-aortic balloon pump use, perioperative myocardial infarction, l
The Journal of Thoracicenal failure, respiratory insufficiency, and life-threatening ar-
hythmia). The operational definitions of each of these variables
ave been described.1 Patients undergoing emergency or salvage
ABG procedures, or CABG in addition to other surgical proce-
ures, were excluded.
The first step in the analysis involved the development of an
nstitutional logistic regression model for adverse outcome using
608 contemporaneous, consecutive patients who underwent elec-
ive and urgent coronary artery bypass between July 1999 and
ecember 2004. Variables considered for the model included age,
ender, preoperative length of stay, ventricular grade, urgency
tatus, primary or redo operation, body mass index, chronic ob-
tructive pulmonary disease, myocardial infarction within 30 days
efore surgery, peripheral vascular disease, Canadian Cardiovas-
ular Society angina class, diabetes (diet-controlled, treatment
ith oral agents, or insulin-dependent), history of transient isch-
mic attack or stroke, left main coronary artery disease, preoper-
tive creatinine, congestive heart failure, palpable aortic athero-
clerosis at surgery, and planned type of CABG procedure (on or
ff pump). By using stepwise logistic regression, allowing for
ntry and removal of variables at the 0.05 level, we determined the
et of predictors of an adverse outcome in this institutional patient
ohort, which included the first author’s patients. This then per-
itted the calculation of the predicted risk of this composite
ccurrence in each of the surgeon’s 793 patients. Both non–risk-
djusted and risk-adjusted CUSUM curves were then generated,
fter specifying the control limits and odds ratio.7,8,10-12 In this
tudy we chose a control limit of 2 and odds ratios of 3/2 (1.5,
50% increase) and 2/3 (0.67, a 33% decrease). The rationale for
hese choices is highlighted in the “Discussion” and the Appendix;
he Appendix includes the CUSUM statistic.
When both the risk-adjusted and non–risk-adjusted CUSUM
urves are being plotted to detect changes in the adverse outcome
ate, patient scores associated with an adverse outcome are posi-
ive, whereas those associated with the avoidance of an adverse
utcome are negative. With the risk-adjusted analysis the “pen-
lty” for an adverse event in a low-risk patient is larger than that
f an adverse event in a high-risk patient.8 The resulting graph
ncludes 2 curves, with the chart designed to identify a decrement
n surgical performance placed above that designed to identify an
mprovement in performance with a decreased complication rate.
he risk-adjusted CUSUM procedure is designed to signal when
he plot falls above the upper control limit or below the lower
ontrol limit, indicating evidence of a 3/2 (50%) increase or 2/3
33%) decrease in the odds ratio, respectively (see CUSUM sta-
istic and weights in Appendix). In addition, the risk-adjusted
USUM plot can be reset to zero after each signal to continue the
uality assurance process for subsequent patients.8 To prove or
isprove our a priori hypothesis, we compared the non–risk-
djusted CUSUM curve of the individual surgeon’s performance
ith the risk-adjusted CUSUM curve. In addition, we further
ssessed the individual surgeon’s risk-adjusted performance using
LAD methods,4,13 which monitored the cumulative expected
inus actual adverse outcome rate for the entire 793-patient ex-
erience. The theoretic relationship between CUSUM and VLAD
ethods has been reviewed in a recent publication by Grunk-
meier and associates,14 and 95% pointwise 2-sided prediction
imits were plotted in our VLAD analysis using the method de-
and Cardiovascular Surgery ● Volume 132, Number 2 387
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CDcribed in that article. Although these prediction limits do not
ccount for multiple testing and are thus difficult to interpret, they
rovide useful information concerning expected variation.14
esults
he overall predicted risk of an adverse outcome was 14.9%
.1% (standard deviation) in the surgeon’s patients versus
3.7%  8% (standard deviation) for all of the other sur-
eons’ patients combined (P  .001). Nonetheless, during
he course of the study the actual adverse event rate was
6/793 (12.1%) and 270/1815 (14.9%) in the surgeon’s
atients versus his colleagues’ patients, respectively (P 
06). The predictors of an adverse outcome in the institu-
ional series of 2608 patients are shown in Table 1. The
osmer-Lemeshow goodness of fit statistic for the multiva-
iable logistic regression model was X82 6.740, P .565,
hereas the C statistic (area under the curve) was 0.688.
he logistic regression equation generated by this analysis
as then used to calculate the risk of an adverse outcome in
ach of the surgeon’s individual cases, which ranged from
.2% to 48.0%.
Results of the non–risk-adjusted CUSUM analysis are
hown in Figure 1. The non–risk-adjusted CUSUM curve
eached below the lower control limit, signifying excellent
ABLE 1. Predictors of an adverse outcome on multivari-
ble analysis (n  2608)
ariable Odds ratio (95% CI) P value
VEF  35% 1.74 (1.33-2.28) .001
reoperative creatinine
120 mol/L
1.73 (1.27-2.34) .001
ncreasing age (per decade) 1.43 (1.26-1.62) .001
ncreasing CCS angina class 1.36 (1.12-1.67) .002
erebrovascular disease (previous
CVA or TIA)
1.59 (1.15-2.20) .006
edo surgery 2.18 (1.17-4.07) .015
OPD 1.41 (1.06-1.88) .018
he intercept term in the multivariable logistic regression model was
5.60. CI, Confidence interval; LVEF, left ventricular ejection fraction; CCS,
anadian Cardiovascular Society; CVA, cerebrovascular accident; TIA,
ransient ischemic attack; COPD, chronic obstructive pulmonary disease.88 The Journal of Thoracic and Cardiovascular Surgery ● Augulinical outcomes, between cases 164 and 313, 323 and 407,
nd 667 and 793. However, the non–risk-adjusted CUSUM
urve transgressed the upper control limit between cases
61 and 478, suggesting a decrement in performance.
As depicted in Figure 2, the intervals of improved per-
ormance on the risk-adjusted CUSUM analysis were sim-
lar to those in the non–risk-adjusted CUSUM analysis.
owever, the risk-adjusted CUSUM curve never trans-
ressed the upper control limit, signifying that cases pre-
eding and including 461 to 478 were at an increased
redicted risk of an adverse outcome. Confirmatory evi-
ence in this regard was provided by a post hoc analysis of
he predicted risk of an adverse outcome in each 50-patient
ohort, as shown in Table 2. The data in that table clearly
how that the second highest predicted risk of death or
ajor complications was in the 50-patient cohort preceding
atients 461 to 478. This increased risk was adjusted for in
he risk-adjusted CUSUM curves in Figure 2, but not in the
on–risk-adjusted Figure 1 curves; thus, the risk-adjusted
USUM curve never transgressed the upper control limit
hroughout the 793-patient cohort. Furthermore, if the risk-
djusted CUSUM curve was reset to zero whenever a
ontrol limit was reached, it still signaled a decrease in
isk-adjusted adverse outcome at 166, 653, and 782 cases
Figure 3).
A VLAD analysis of the cumulative expected minus
ctual adverse outcome rate (Figure 4) showed that there
ere 23 fewer adverse events in the surgeon’s 793-patient
xperience than predicted by the institutional multivariable
ogistic regression model. The pointwise prediction limits in
igure 4 were included as a useful way of assessing vari-
bility, but they do not account for multiple testing.14 Sim-
lar to the pattern shown by the risk-adjusted CUSUM
urves, the VLAD analysis demonstrated an increasing
rend of adverse outcomes at the beginning of the cohort and
rom cases 400 to 478, versus a decreasing trend of adverse
vents in the remainder of the surgeon’s experience.
iscussion
ncreasing attention has been paid to the use of sequential
robability ratio tests (including the CUSUM method) in the
Figure 1. Non–risk-adjusted CUSUM analysis of
the surgeon’s adverse outcome rate. The curve
designed to identify a decrement in surgical per-
formance is placed above that designed to iden-
tify improvement in performance with a de-
creased complication rate. Pre-set control limits
(dashed horizontal lines).st 2006
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CDnalysis of surgical results during the past few years,1-9,15
fter the initial application of this technique in neonatal
eart surgery by de Leval and colleagues.16 Our group has
sed non–risk-adjusted CUSUM methods to analyze the
earning curve of a cardiac surgeon in the first 10 years of
ractice15 to examine the impact of a policy change from
n-pump to off-pump CABG,1 to assess the learning curve
n robotic-assisted beating heart CABG,2 and to analyze a
urgeon’s early experience with elective open abdominal
ortic aneurysm repair.17 All of these studies showed that
he non–risk-adjusted CUSUM method was more sensitive
han standard statistical techniques such as the chi-square
est in identifying a cluster of surgical failures or successes.
onetheless, a recent article suggested possible methodologic
imitations of our non–risk-adjusted method of CUSUM
nalysis.4 Furthermore, it has been presumed that contem-
orary CUSUM analyses should ideally be risk-adjusted,
ecause the non–risk-adjusted method treats all patients
ABLE 2. Predicted risk of major complications or death in
ach 50-patient interval in the surgeon’s cohort
urgery no. Risk Mean (SD)
No. of deaths or major
complications (%)
1-50 0.126 (0.067) 8 (16.0%)
51-100 0.142 (0.092) 8 (16.0%)
101-150 0.146 (0.083) 3 (6.0%)
151-200 0.142 (0.074) 2 (4.0%)
201-250 0.130 (0.068) 7 (14.0%)
251-300 0.146 (0.077) 8 (16.0%)
301-350 0.137 (0.070) 5 (10.0%)
351-400 0.151 (0.071) 8 (16.0%)
401-450 0.166 (0.080) 10 (20.0%)
451-500 0.163 (0.087) 8 (16.0%)
501-550 0.135 (0.081) 5 (10.0%)
551-600 0.172 (0.092) 6 (12.0%)
601-650 0.156 (0.091) 6 (12.0%)
651-700 0.144 (0.073) 4 (8.0%)
701-750 0.164 (0.081) 6 (12.0%)
751-793 0.166 (0.093) 2 (4.7%)sD, Standard deviation.
The Journal of Thoracicdentically and does not take into account variations in
reoperative risk. The practical importance of risk adjust-
ent was highlighted in the current study, in which the
redicted risk of an adverse outcome in the surgeon’s pa-
ients ranged from 2.2% to 48.0%.
The method of risk-adjusted CUSUM analysis used in
his study was developed by Steiner and associates10,11 and
as used to track risk-adjusted outcomes in a tertiary refer-
al adult intensive care unit.12 The latter study detected a
ecrease in risk-adjusted intensive care unit mortality,
hich was temporally related to increased senior staffing
evels and quality improvement efforts.12 The Vascular Sur-
ery group at the London Health Sciences Centre recently
sed the same technique to analyze risk-adjusted outcomes
fter elective open abdominal aneurysm repair7 and rup-
ured abdominal aortic aneurysm surgery.8 The former
tudy demonstrated improved results after the first year of
xperience, which coincided with the adoption of routine
ntraoperative cell-saver use.7 In the second study, the risk-
djusted CUSUM curve was set to signal with a halving or
oubling of the odds ratio; the CUSUM plot signaled at
atient 45 by crossing the lower control limit, indicating
mproved risk-adjusted outcomes one third of the way
hrough the patient cohort.8
Although the theoretic advantages of a risk-adjusted, as
pposed to a non–risk-adjusted, CUSUM analysis of CABG
utcomes are presumed, to our knowledge only 1 “head-to-
ead” comparison between the 2 methods has been pub-
ished, in a biostatistical journal.10 However, a recent pub-
ication compared risk-adjusted versus non–risk-adjusted
USUM analyses in 2 cohorts of patients undergoing heart
r lung transplantation.18 The findings of our study indi-
ated that despite wide variations in preoperative patient
isk, the non–risk-adjusted (Figure 1) and risk-adjusted
Figure 2) CUSUM curves paralleled each other closely,
ignifying that the overall impact provided by risk adjust-
ent was of modest clinical significance. Nonetheless, there
ere more extreme fluctuations of the CUSUM curves in
he non–risk-adjusted analysis than in the risk-adjusted analy-
Figure 2. Risk-adjusted CUSUM analysis of the
surgeon’s adverse outcome rate. The curve
designed to identify a decrement in surgical per-
formance is placed above that designed to iden-
tify improvement in performance with a de-
creased complication rate. Pre-set control limits
(dashed horizontal lines).is. Furthermore, although improved performance was de-
and Cardiovascular Surgery ● Volume 132, Number 2 389
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CDected at similar intervals in the non–risk-adjusted and risk-
djusted CUSUM analyses, the non–risk-adjusted curve
howed an increased adverse outcome rate between patients
61 and 478. In the risk-adjusted analysis, the curve did not
ome close to reaching the upper control limit, implying that
he patients preceding and including 461 to 478 were at a
igher predicted risk. This qualitative impression was con-
rmed in a post hoc analysis of the predicted risk of major
omplications or death in each 50-patient interval in the
urgeon’s cohort, as presented in Table 2. Indeed, patients
00 to 500 had the highest predicted risk of an adverse
utcome in the series to that point. It is interesting that
atients 551 to 600 had an even higher predicted risk, yet
he non–risk-adjusted CUSUM curve was relatively flat and
he risk-adjusted CUSUM curve was downsloping during
his interval.
Although this study showed that risk-adjusted CUSUM
nalyses have advantages over non–risk-adjusted CUSUM
ethods in a retrospective analysis of surgical performance,
he greatest advantage of the former technique will likely be
hen it is used prospectively. An analytic technique that
ccounts for the patient’s preoperative risk will facilitate an
ccurate analysis of factors that have an immediate and90 The Journal of Thoracic and Cardiovascular Surgery ● Auguirect impact on clinical practice. Furthermore, the risk-
djusted CUSUM curve can be reset to zero whenever a
oundary line is transgressed, thus continuing the quality
ssurance process for subsequent patients. This zero reset
ethod could also facilitate an interpretation of the impact
f new quality improvement initiatives on postoperative
utcomes.
With a CUSUM analysis there is an inherent tradeoff in
he choice of the control limit. A large limit provides
rotection against false signals resulting from chance, but
ill be slow to detect a change in the process performance
ie, odds ratio), whereas a small control limit will detect
hanges quickly but have more frequent false signals result-
ng from chance when the process is unchanged. We can
uantify the CUSUM chart performance in terms of the
verage run length (ARL), which represents the average
umber of patients before a signal. Large ARLs are better
hen the process performance is unchanged, whereas small
RLs are more optimal for large process changes. Given the
bserved patient mix in our study, a control limit set at 2.0
esulted in an ARL of 604. Thus, even if the odds ratio is
nchanged, one would expect a signal on average for every
04 patients. This value of ARL was deemed to provide
Figure 3. Risk-adjusted CUSUM analysis of the
surgeon’s adverse outcome rate, with resetting
of the CUSUM curve to zero whenever a pre-set
control limit was reached. The curve designed to
identify a decrement in surgical performance is
placed above that designed to identify improve-
ment in performance with a decreased compli-
cation rate. Pre-set control limits (dashed hori-
zontal lines).
Figure 4. VLAD analysis of the surgeon’s cumu-
lative expected minus actual adverse outcome
rate. The 95% pointwise 2-sided prediction limits
are plotted as aids in interpretation.14st 2006
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CDeasonable protection from frequent false alarms, while
eing sensitive to changes in the odds ratio.
The limitations of this study include the fact that it
ompares only a single surgeon’s patient outcomes with
hose of his colleagues in a single institution; nonetheless,
he 2 patient cohorts numbered 793 and 2608 patients,
espectively, and the experience spanned 5 years. A second
imitation is that the primary outcome variable used repre-
ented the composite occurrence of mortality and/or any of
0 predefined major complications. Some of these compli-
ations (eg, reoperation for bleeding) are less consequential
han others, such as a perioperative stroke. A more targeted
nalysis incorporating only irrevocable adverse outcomes
uch as mortality and stroke could have been performed, but
ould have required a larger number of patients to generate
he same statistical power. Another potential limitation is
he choice of odds ratio of 1.5 (3/2) and 2/3 and a control
imit of 2 in this study. Odds ratios of 3/2 and 2/3 were
sed because a relative increase of 3/2 or decrease of 2/3 in
he composite outcome was deemed to be clinically signif-
cant. Furthermore, the control limit was set lower than in a
ecent risk-adjusted CUSUM analysis of early mortality
fter ruptured abdominal aortic aneurysm repair,8 so that a
ecrement or improvement in surgical performance could
e more rapidly detected. Use of a control limit less than 2.0
ould have significantly decreased the ARL at which a
ositive or negative deviation in care would have been
etected by chance alone, and would likely have been too
ensitive an analysis for this study.
onclusion
his study demonstrated that the results of the non–risk-
djusted and risk-adjusted CUSUM analyses paralleled each
ther; however, there were incremental advantages to the
atter technique, which did not inappropriately signal a
ecrement in performance when the predicted risk was high.
uture studies should use risk-adjusted CUSUM methods
rospectively to assess the impact of new clinical protocols
nd quality assurance methods on surgical outcomes.
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ppendix
efinition of CUSUM statistic and weights in
his study
t
  max 0, Xt1
  wt and Xt
  min 0, Xt1
  wt are used
or the CUSUM statistic to detect increases and decreases, respec-
ively. In both expressions the weights are based on the formula
elow, where pt is the predicted preoperative risk (as given by the
ogistic regression) and for Xt and Xt ORA is 3/2 and 2/3, respec-
ively.
wt
log ORA1 pt ORApt if adverse outcome for patient t
1log1 pt ORApt otherwise
and Cardiovascular Surgery ● Volume 132, Number 2 391
